Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial
1. 当前求助状态已完结, 请及时下载应助文件
2. 系统将在 2026-04-16 00:42:11 删除文件
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: DOI: 10.1016/S1470-2045(19)30027-0
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S1470204519300270
其他信息:
出版社: Elsevier BV
作者: Cathy Eng; Tae Won Kim; Johanna Bendell; Guillem Argilés; Niall C Tebbutt; Maria Di Bartolomeo; Alfredo Falcone; Marwan Fakih; Mark Kozloff; Neil H Segal; Alberto Sobrero; Yibing Yan; Ilsung Chang; Anne Uyei; Louise Roberts; Fortunato Ciardiello; JB Ahn; J Asselah; S Badarinath; S Baijal; S Begbie; S Berry; JL Canon; RG Carbone; A Cervantes; YJ Cha; K Chang; A Chaudhry; E Chmielowska; SH Cho; D Chu; F Couture; J Cultrera; D Cunningham; E Van Cutsem; PJ Cuyle; J Davies; S Dowden; M Dvorkin; V Ganju; RV Garcia; R Kerr; TY Kim; K King; J Kortmansky; M Kozloff; KO Lam; J Lee; AS Lee; B Lesperance; G Luppi; B Ma; E Maiello; R Mandanas; J Marshall; G Marx; S Mullamitha; M Nechaeva; JO Park; N Pavlakis; CG Ponce; P Potemski; S Raouf; J Reeves; N Segal; S Siena; A Smolin; JO Streb; A Strickland; E Szutowicz-Zielinska; JM Tabernero; B Tan; JS Valera; M Van den Eynde; P Vergauwe; M Vickers; M Womack; M Wroblewska; R Young
